Detalles de la búsqueda
1.
Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection.
Br J Cancer
; 123(1): 92-100, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32376890
2.
Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
BMC Cancer
; 20(1): 642, 2020 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32650743
3.
Histopathology-based immunoscore predicts recurrence for intrahepatic cholangiocarcinoma after hepatectomy.
Cancer Immunol Immunother
; 68(8): 1369-1378, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31338558
4.
Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma.
BMC Med
; 17(1): 106, 2019 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31164128
5.
Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
BMC Cancer
; 17(1): 762, 2017 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29137600
6.
Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration.
Cell Oncol (Dordr)
; 2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38607517
7.
CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor.
Cell Discov
; 9(1): 25, 2023 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36878933
8.
Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation.
Hepatol Int
; 17(4): 927-941, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37031334
9.
Single-cell and spatial architecture of primary liver cancer.
Commun Biol
; 6(1): 1181, 2023 11 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37985711
10.
Exploring pathological signatures for predicting the recurrence of early-stage hepatocellular carcinoma based on deep learning.
Front Oncol
; 12: 968202, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36059627
11.
Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study.
Mol Oncol
; 16(2): 549-561, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34543520
12.
Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study.
BJS Open
; 6(5)2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36125345
13.
Cystathionine ß-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesis.
J Immunother Cancer
; 9(8)2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34413167
14.
Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resection.
Ann Transl Med
; 8(7): 487, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32395531
15.
Impact of antimalarial (AM) on serum lipids in systemic lupus erythematosus (SLE) patients: A systematic review and meta-analysis.
Medicine (Baltimore)
; 98(14): e15030, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30946340
16.
Prognostic Value and Predication Model of Microvascular Invasion in Patients with Intrahepatic Cholangiocarcinoma.
J Cancer
; 10(22): 5575-5584, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31632502
17.
Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma.
Cancer Manag Res
; 11: 5187-5195, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31239773
18.
Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study.
Aging (Albany NY)
; 11(23): 11111-11123, 2019 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31829979
19.
Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching Analysis.
J Cancer
; 9(6): 1106-1112, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29581790
20.
A Novel Risk prediction Model for Patients with Combined Hepatocellular-Cholangiocarcinoma.
J Cancer
; 9(6): 1025-1032, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29581782
Resultados
1 -
20
de 20
1
Próxima >
>>